Omenn Syndrome in the Context of Other B Cell-Negative Severe Combined Immunodeficiencies
Anna Villa, MD, Christina Sobacchi, PhD and Paulo Vezzoni, MD, PhD
Click on the icon on the upper right hand side for the article by Anna Villa, MD, Christina Sobacchi, PhD and Paulo Vezzoni, MD, PhD, published in IMAJ.
IMAJ 2002; 4; March; 218-221
Abstract
Severe combined immunodeficiencies represent a heterogeneous group of hereditary defects of the immune system that affect both T and B cells and whose etiology has only recently begun to be understood. A portion of these SCID patients bear a defect in either of the two recombination-activating genes, Rag-1 or Rag-2, while others have mutations in a newly identified gene, Artemis. Omenn syndrome is an unusual severe immunodeficiency with T cells but no B cells, and peculiar features also due to a defect in Rag-1 or Rag-2 genes. All these three forms are characterized by an impairment of the VDJ recombination, the process that insures the somatic diversification of immunoglobulin and T cell receptor-encoding genes. Recent findings have enabled us to better understand the pathophysiology of these three immunodeficiencies, which affect the V(D)J recombination process to a different extent and in different ways.
Key words